| CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients L Barrera, E Montes-Servín, JM Hernandez-Martinez, MÁ García-Vicente, ... British journal of cancer 117 (3), 385-397, 2017 | 93 | 2017 |
| Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients O Arrieta, E Montes-Servín, JM Hernandez-Martinez, AF Cardona, ... Oncotarget 8 (60), 101994, 2017 | 87 | 2017 |
| Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis L Barrera, E Montes-Servín, A Barrera, LA Ramírez-Tirado, ... Annals of Oncology 26 (2), 428-435, 2015 | 87 | 2015 |
| Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non … L Barrera, E Montes-Servín, JM Hernandez-Martinez, M Orozco-Morales, ... Cancer Immunology, Immunotherapy 67, 1393-1406, 2018 | 45 | 2018 |
| Clinical evaluation of BRCA1/2 mutation in Mexican ovarian cancer patients D Gallardo-Rincón, RM Álvarez-Gómez, E Montes-Servín, ... Translational oncology 13 (2), 212-220, 2020 | 25 | 2020 |
| Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention AR Pérez-Martín, D Castro-Eguiluz, L Cetina-Pérez, Y Velasco-Torres, ... Bosnian Journal of Basic Medical Sciences 22 (4), 499, 2022 | 13 | 2022 |
| Experiencia con el uso de olaparib en pacientes con cáncer de ovario D Gallardo-Rincón, G Alamilla-García, E Montes-Servín, ... Gaceta médica de México 155 (6), 585-589, 2019 | 5 | 2019 |
| Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12 D Gallardo-Rincón, E Montes-Servín, G Alamilla-García, E Montes-Servín, ... Frontiers in Genetics 13, 863956, 2022 | 3 | 2022 |
| Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México D Gallardo-Rincon, A Toledo-Leyva, A Bahena-Gonzalez, ... Archives of Gynecology and Obstetrics 304, 773-782, 2021 | 3 | 2021 |
| Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first-or second-generation EGFR-TKIs O Arrieta, JM Hernandez-Martinez, E Montes-Servín, D Heredia, ... Cancer Biomarkers 32 (2), 123-135, 2021 | 2 | 2021 |
| Interplay between immune cells in lung cancer: beyond T lymphocytes JM Hernandez-Martinez, E Vergara, E Montes-Servín, O Arrieta Translational Lung Cancer Research 7 (Suppl 4), S336, 2018 | 2 | 2018 |
| Clinical evaluation of the utility of a liquid biopsy (circulating tumoral cells and ctDNA) to determine the mutational profile (EGFR, KRAS, ALK, ROS1 and BRAF) in advanced … L Barrera, E Montes-Servin, JR Borbolla, L Arnold, J Poole, V Alexiadis, ... Annals of Oncology 27, vi526, 2016 | 2 | 2016 |
| P1. 07-040 prognosis-relevant subgroups in NSCLC according to granulocytic myeloid-derived suppressor cell frequency and cytokine levels L Barrera, E Montes-Servin, JH Martinez, MO Morales, EM Servin, ... Journal of Thoracic Oncology 12 (11), S2011-S2012, 2017 | 1 | 2017 |
| MA14. 02 Evaluation of PD1/PDL1 Expression on Peripheral Blood Cells Subpopulations in Patients with Non-Small Cell Lung Cancer O Arrieta, E Montes-Servín Journal of Thoracic Oncology 12 (1), S422-S423, 2017 | 1 | 2017 |
| Myeloid Derived Supressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer O Arrieta Rodriguez, R Morales-Flores, A Garcia-Vicente, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S255-S255, 2015 | 1 | 2015 |
| Overexpression of CD47, Decrease of Apoptosis and Phagocytosis of Neutrophils in Advanced Non-Small Cell Lung Cancer Patients L Barrera, O Arrieta Rodriguez, R Morales-Flores, A Garcia-Vicente, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S266-S266, 2015 | 1 | 2015 |
| 68P Prognosis of ovarian cancer patients with the Mexican founder mutation (a BRCA1 long genomic rearrangement) compared with other BRCA1/2 mutations J Bahena, E Montes-Servin, E Gonzalez-Ibarra, J Sanchez-Flores, ... ESMO Open 8 (1), 2023 | | 2023 |
| 767P Retrospective analysis of the impact of bevacizumab dose-intensity on the survival of platinum-resistant ovarian cancer patients JA Bahena, L Cetina-Pérez, D Gallardo-Rincón, P Cabrera-Galeana, ... Annals of Oncology 32, S750-S751, 2021 | | 2021 |
| Half-dose olaparib reduction: Safe and efficient dose in multi-treated Mexican ovarian cancer patients. D Gallardo-Rincon, G Alamilla, E Montes-Servín, D Michel-Tello, ... Journal of Clinical Oncology 37 (15_suppl), e17101-e17101, 2019 | | 2019 |
| Clinical benefit of bevacizumab in Mexican ovarian cancer patients according to the intention of treatment by the oncologist. D Gallardo-Rincon, A Bahena-Gonzalez, E Montes-Servín, ... Journal of Clinical Oncology 37 (15_suppl), e17097-e17097, 2019 | | 2019 |
Lourdes BarreraExecutive Director, Global Medical Affairs, Precision MedicineVahvistettu sähköpostiosoite verkkotunnuksessa merck.com
